Background: Glaucoma is a chronic neurodegenerative disease, characterized by progressive, permanent visual loss resulting from irreversible retinal ganglion cells (RGC) degeneration. Replacement of degenerated RGCs is a promising strategy to restore visual function. We previously demonstrated FGF2 induced differentiation of mouse embryonic stem cells (ESC) to RGC lineage, capable of retinal Ganglion Cell Layer (GCL) integration upon transplantation in mice. Here, we evaluated possible improvement of visual function by transplantation of ES cell derived neural progenitors in RGC depleted glaucoma mice models. Methods: ESC derived neural progenitors (ES-NP) was transplanted into NMDA (N-Methyl-D-Aspartate) injected, RGC-ablated mouse models and a pre-clinical glaucoma mouse model (DBA/2J) having sustained higher intra ocular pressure (IOP). Visual acuity and functional integration was evaluated by behavioural experiments and immunohistochemistry, respectively. Results: Transplantation of GFP expressing ES-NPs in NMDA injected RGC depleted mice, differentiated to RGC lineage and got integrated into GCL. An improvement in visual acuity was observed after two months of transplantation, when compared to the pre-transplantation values. Expression of c-Fos in the transplanted cells, upon light induction, further suggests functional integration into the host retinal circuitry. However, transplantation in DBA/2J mouse showed no significant improvement in visual functions, due to the cell death by inherent high IOP.
Introduction
Glaucoma is a chronic neurodegenerative disease, characterized by progressive, permanent visual loss resulting from the degeneration of retinal ganglion cells (RGCs) 1 . An increased intra ocular pressure (IOP) resulting from the disrupted dynamics of aqueous humor flow is mainly attributed to the progressive damage of RGC and their axons 2 . Current treatment strategies focus mainly on pharmacological and surgical interventions to control the elevated IOP, which is the prime risk factor for glaucoma 3 . However, the irreversible vision loss as well as RGC degeneration often persists, even when IOP is controlled.
Thus selective replacement of degenerated RGCs to restore lost visual function f o r m s an alternative strategy to regenerate the RGC layer 4 . However, vision restoration at translational level in clinics has been hindered by several challenges; such as source of the stem cells, differentiation into appropriate cell type, transplantation approaches, survival and functional integration of cells into the target retina 5 . Additionally, to establish functional neuronal connectivity, optimal microenvironment mediated by the trophic factors is crucial 6 .
Moreover, survival of the transplanted cells also depends on the glaucomatous retinal microenvironment.
Although several studies in animal models and isolated clinical trials for cell transplantations have been reported in ocular neurodegenerative diseases 4, 7, 8 9 , results
were not substantial to be translated as a therapeutic measure in clinics, owing to the safety concerns, elusive molecular mechanism in establishing the functional connectivity and survival of transplanted neurons 8 . Despite these advances less progress has been made in cell replacement strategies pertaining to RGC loss.
We have previously demonstrated the potential of embryonic stem (ES) cells to differentiate along RGC lineage induced by growth factors, which were capable of integrating into the Ganglion Cell Layer (GCL) of the retina upon transplantation 10 . In the current study, we evaluated restoration of visual function by transplantation of ES cell derived neural progenitors in (i) chemically-induced glaucoma model generated by were compared with prior to that of transplantation. Further the transplanted animals were sacrificed for immunohistochemical characterization of retina.
Behavioral Analysis

Optokinetic tracking experiments
We used an optokinetic tracking system (OptoMotry, Cerebral Mechanics Inc.) to evaluate the visual acuity by measuring the image-tracking reflex of mice 13 . Visual stimuli are projected on to the monitors so that a virtual cylinder with rotating gratings (sine wave grating) is produced. The mouse was allowed to track the grating and the tracking response was recorded. All acuity thresholds were determined using the staircase method with 100% contrast 14 .
Light Avoidance Experiment
The innate aversion of mice to the brightly illuminated area was utilized here to evaluate the visual responses. The light avoidance test was conducted using a light-dark box consisting two equal sized compartments (20cm × 20cm). The light compartment was kept eliminated at a luminosity of 600 lux. An opening (7.5 × 7.5 cm) was located in the wall between the two chambers allowing free access between the light and dark compartments.
The mice was placed in the light chamber to explore the box for five minutes and their movement across the chambers was tracked by computerized video tracking system (Anymaze, Stoelting, USA). The fraction of time spent by the mice in the open illuminated space is noted for calculating the percentage of time spent in light zone.
Anterograde tracing of RGC axonal projections in NMDA model
NMDA injected mice (n = 5) and non-injection controls (n = 5) were anesthetized as mentioned previously and 2μl of cholera toxin B subunit conjugated with Alexa Fluor 488 (CTB-488, Invitrogen, CA) was injected intravitreally to track the RGC axonal projections.
Three to four days after injection, the retina and brain were fixed by perfusing with 4%
Paraformaldehyde (PFA). The brain samples were dissected and coronal sections were taken for further analysis. RGC axonal targets in the brain such as Suprachiasmatic Nuclei (SCN), Lateral Geniculate Nuclei (LGN) and Superior Colliculus (SC) were analyzed for RGC axonal projection innervations. The levels of fluorescence of maximum RGC projections in brain regions and total fluorescence levels were measured with Image-J software (http://rsbweb.nih.gov/ij/) as described previously 15 .
Whole mount Retina Immunostaining
To evaluate the RGC loss, NMDA injected animals (n = 5) and non-injection control animals (n = 5) were sacrificed and the eyes were fixed in 4% PFA for 30 minutes followed by dissection of retina. The retina was again fixed in 4% PFA for one hour followed by blocking in 0.6% blocking solution. The whole mount retina was incubated with rabbit anti-Brn3a primary antibody (1:500, Chemicon) at 4°C for 2-3 days followed by washing with 1X PBS three times for 30 minutes each. Goat anti-Rabbit IgG (H+L), Alexa Fluor 594 (1:400, Molecular Probes) was used as secondary antibody and incubated for two days at 4°C.
In order to assess functional integration of transplanted cells, we analyzed the expression of an immediate early gene c-Fos in transplanted NMDA injected mice housed in normal 12:12 light-dark cycle. Mice were given a light pulse of 500 lux intensity for 30 minutes after which mice were placed back in dark for 90 minutes. Animals were subsequently sacrificed, enucleated and whole mount retinal preparation were made as described earlier. The whole mount retinas were then incubated with rabbit anti-c-Fos antibody (1:10,000, Calbiochem) at 4°C for 2 days followed by secondary staining with Goat The slides were viewed and imaged in an upright fluorescent microscope (Carl Zeiss, Oberkochen, Germany).
Statistical Analysis
All data were obtained by at least three independent experiments and represented as Mean ± SD. Statistical significance between two groups was calculated by unpaired t-tests assuming two-tailed distribution and equal variances. P value <0.05 was considered as statistically significant.
Results
Visual acuity of the NMDA injected mice is significantly reduced along with RGC loss
The RGC ablated mice model was generated by intravitreal injection of NMDA (100µM) to induce excitotoxic damage to RGCs. After one week of NMDA injection, there was ~50% reduction in the number of Brn3a positive RGCs in the whole mount retina (33.85 ± 4.71) when compared to control animals with no NMDA injection (57.74 ± 4.66, p<0.001, Fig.1 A-F&G) . In order to understand the possibility of whether the NMDA injected retina could regenerate the lost RGC's induced due to excitotoxicity, we also analysed the retina after 40 days of NMDA injection and observed that the loss is irreversible (Fig. S1A, B) .
Visual acuity of the NMDA injected mice was tested by its ability to track black and white gratings on a virtual rotating cylinder using an optokinetic tracking system ( Fig.1 H) . Our results showed that there was a significant reduction in visual acuity (cycles/degree) of NMDA injected animals (0.209 ± 0.053, p < 0.001, Fig.1J ), compared to the pre-injection controls 0.427 ± 0.08. A light avoidance test ( Fig.1 I) also supported the above observation,
where the pre-injection controls avoided bright light and spent only ~17% of the time in light zone. The NMDA injected animals showed comparatively less light avoidance behaviour and spent ~43%, (p < 0.001) of time in the light zone, (Fig.1 K) . Similar results were also observed after 40 days of NMDA injection indicating that the animals have lost visual functions permanently with no recovery (Fig. S1C) . These results clearly suggested that ablation of RGCs by NMDA injection, leads to impairment in visual functions.
We further investigated RGC innervations of brain targets, both in image forming visual function centres (LGN and SC) and non-image forming visual function centres (SCN).
Anterograde tracing experiments with intravitreal injection of Cholera toxin B-488 was performed to track the RGC axonal projections. RGC innervations into the dorsal LGN of NMDA injected animals (218.00 ± 7.86) was significantly reduced compared to that of control animals (682.00 ± 42.41, p < 0.001, Fig.2 A-D&E) . Similarly, SC also had significantly less RGC innervations in NMDA injected animals (274.24 ± 97.32) compared to that of controls (2502.85 ± 6.77, p < 0.001, Fig.2 F-I&J) . However, the RGC innervations to the SCN, the brain region responsible for regulating the circadian rhythm were intact (Control = 634.47 ± 53.53, NMDA=404.28 ± 80.65, p < 0.21, Fig.2 K-N&O. These observations were in agreement with our results where the NMDA injected animals showed drastically reduced visual acuity which might be due to the lesser RGC innervation in the image forming centres of the brain as of the RGC loss. The intact innervation in the SCN was in agreement with the reports that the NMDA injection does not affect ipRGCs 18 . We thus used animals, after 7 days of NMDA injection, as RGC ablated model for the transplantation studies.
ES-NPs transplantation in RGC depleted mice improved visual function
We have previously reported that FGF2-induced ES-NPs were able to differentiate along RGC lineage evidenced by the expression of RGC regulators and markers 10 (Fig. S2 A-N). Further we have also shown that ES-NPs, after exposure to FGF2, were capable of integrating and differentiating into RGCs in vivo upon transplantation 10 . In the present study we adopted the same strategy. The FGF2 treated, differentiating ES-NPs (GFP expressing)
were transplanted intravitreally into the NMDA injected-RGC depleted mice model. The animals were subjected to behavior tests two months after transplantation. Significant improvement in visual acuity was observed in transplanted animals as evidenced from optokinetic response, compared to NMDA injected animals, before transplantation (Transplanted = 0.233 ± 0.07, NMDA injected, prior to transplantation = 0.138 ± 0.07, p < 0.05 Fig.3 K) . Though, we observed an improved visual function in NMDA model, we could not observe integration of transplanted cells into the optic nerve.
In the light avoidance test, animals after transplantation spent less time (90. To confirm the integration of the transplanted cells into the GCL of host retina, the animals were sacrificed after behavioral analysis and whole mount retinal staining was done.
Extensive integration of GFP expressing cells throughout the surface of retina with distinct RGC morphology was observed ( Fig.3 A-C) . The RGC lineage was also confirmed by immunostaining with the RGC marker, calretinin (Fig.3 D-G) . Retinal sections also showed extensive integration of GFP expressing cells in the RGC specific GCL (Fig.3 H-J) .
To test whether the transplanted cells form functional neural circuits with the photoreceptor expressing cells, expression of c-Fos, an immediate early gene, was probed in the transplanted cells, in response to light induction. The transplanted GFP-expressing cells showed c-Fos expression, suggestive of getting activated by the light stimulus ( Fig.3 M-P) .
Thus the results are suggestive of transplanted cells capable of being functionally integrated into the host retinal circuitry by forming connections with the photoreceptor expressing host cells. Although the number of cells co-expressing c-Fos was less in number, this was a very promising result, which substantiates our results of improved visual acuity evidenced from behavioural experiments ( Fig.3 K, L) .
ES-NPs transplantation in DBA/2J mice did not show significant improvement in visual functions
We further extended our transplantation protocol to the pre-clinical glaucoma model, Fig.4 B) .
FGF2-induced GFP-expressing ES-NPs was transplanted into the visually challenged
DBA/2J animal. Visual functions by behavioural experiments were tested after two months of transplantation. As evidenced from optokinetic response and light avoidance behaviour, visual acuity in DBA/2J animals did not improve after transplantation ( Fig.4 A, B) . Moreover DBA/2J mice showed highly disorganized GCL with very low number of RGCs which are dispersed irregularly throughout (Fig.4 E) compared to that of controls ( Fig.4 C) . We speculate that the elevated IOP inherent to the DBA/2J mice might induce oxidative stress 19 on the transplanted cells, preventing them from proper differentiation and innervation, limiting the improvement in visual acuity. Therefore, by comparing the NMDA and DBA/2J
models, it appears that control of IOP is much more crucial for the transplanted cells to integrate efficiently for functional recovery.
Discussion
Large number of studies has been reported, where photoreceptor transplantation in appropriate disease models has been done with partial restoration of vision 4, [20] [21] [22] [23] Improvement of visual functions evidenced by electroretinogram (ERG) and visual evoked potential (VEP) following the transplantation of retinal progenitor cells in rat models of retinal degeneration was also reported recently 26, 27 .
Nevertheless, in our study integration of transplanted cells into optic nerve was not observed, which was in line with reports where transplanted cells were seen to extend processes into the RGC layer, but not towards the optic nerve 25, 28 . We speculate that the transplanted cells integrated into the GCL layer may establish local interneuron connectivity and also secrete neurotrophic factors exerting a protective effect on optic nerve preventing the further neuronal loss and, thus resulting in improved visual functions 25, 29 . Moreover, NMDA-induced model showed only ~50% RGC depletion which suggested possible contribution of the transplanted cells in survival of remaining RGCs in the retina and their axons providing a repairing effect on optic nerve that innervate the visual centres in the brain.
However, present study was limited by the neuronal tracking to show the restored neuroanatomy in the visual centres in brain. Further electrophysiological evidences were also lacking to support the recovery, but the improved visual functions evidenced from behavioural studies along with the observations from c-Fos expression results clearly showed functional integration of the transplanted cells proving intact functional anatomy. Though this integration was promising the number of c-Fos co-expressing cells was less, which could be 1 attributed to the lesser RGC yield after FGF2 induced differentiation 10 . Integration of transplanted primary mice RGCs in uninjured rat retina was recently reported with axons extending to visual centres in brain with electrical excitability and light response 30 . This integration might have been benefitted from the factors derived from donor RGCs as it was isolated from developing retina 28, 31 . Therefore future studies are warranted for precise RGC fate acquisition from pluripotent stem cell source with good yield for testing long range arborisation to visual centres after transplantation.
Meanwhile, the DBA/2J animals did not show any significant improvement in vision after transplantation. This could be attributed to the inherent high IOP in DBA/2J animals resulting in the degeneration of the transplanted cells owing to the oxidative stress 19 . Since the GCL of retina is highly dispersed in these mice model, it can be speculated that the transplanted cells were not able to integrate. Thus the dispersed nature of the GCL may limit the scaffolding support to the transplanted cells. Moreover, the transplantation was done at the age of 8 months, where RGC degeneration occur maximum because of high IOP implying the requirement of pharmacological IOP alleviation for effective transplantation. However, our study was limited by transplantation experiments in DBA/2J controlled for IOP.
Therefore, for the survival of transplanted cells in glaucoma, strategies to control the IOP are warranted.
Although, there was a recovery of visual function in the NMDA model, it can be considered as the recovery from the pathological state of glaucoma by replenishment of cells.
Since elevated IOP forms a critical characteristic feature of glaucoma and the NMDA model The funding body has no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript. 
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